While one study found lower rates of preterm birth alongside higher rates of hypertensive disorders, another found fewer ...

The FDA recently removed semaglutide from its drug shortage list, which has not been considered commercially available since ...

For individuals with type 2 diabetes (T2D), semaglutide is associated with a modestly increased risk for nonarterit ...

Hims & Hers stock drops 26% as FDA resolves semaglutide shortage, threatening GLP-1 revenue. Click here to find out why HIMS ...

None ...

The popular medications may still suffer from local shortages, but FDA is confident that the national supply will remain ...

People with a high body weight living in England can now access subsidized weight-loss drugs to treat their obesity. This ...

Drug compounders aren’t ready to give up their ability to produce off-brand versions of Novo Nordisk’s weight-loss drug ...

Hims & Hers (NYSE: HIMS) stock was a heartening comeback story on Wednesday, following something of a rout earlier in the ...

The lawsuit, filed by the Outsourcing Facilities Association , FarmaKeio Custom Compounding and North American Custom Laboratories in the U.S. District Court for the Northern District of Texas, argues ...

Q. My very experienced cardiologist noted recently that for many patients, including me, losing weight improves many heart health issues. It really doesn’t matter how the weight loss happens, as long ...